Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

US experienced higher COVID-19 mortality during delta and omicron waves

A recent study estimates coronavirus disease 2019-related mortality and excess all-cause mortality in the US and 20 peer countries during the delta and omicron waves of infection.

22 Nov 2022

Treating long covid is rife with guesswork

Medical equipment is still strewn around the house of Rick Lucas, 62, nearly two years after he came home from the hospital. He picks up a spirometer, a device that measures lung capacity, and takes a deep breath — though not as deep as he'd like.

22 Nov 2022

Schools, sheriffs, and syringes: State plans vary for spending $26B in opioid settlement funds

With more than 200 Americans still dying of drug overdoses each day, states are beginning the high-stakes task of deciding how to spend billions of dollars in settlement funds from opioid manufacturers and distributors.

22 Nov 2022

California aims to maximize health insurance subsidies for workers during labor disputes

This spring, Chevron workers testified that the company revoked health coverage for hundreds of members of the United Steelworkers Local 5 at the Richmond, California, refinery during a strike that ultimately lasted two months.

22 Nov 2022

Exploring antibiotic resistance in the EU

Antibiotic resistance is one of the greatest threats to global human health and to development.

22 Nov 2022

Elevated incidence and risk for a new diagnosis of diabetes after COVID-19

In a recent study published in the journal BMC Medicine, researchers estimated the prevalence of new-onset diabetes following coronavirus disease 2019 (COVID-19).

21 Nov 2022

The WHO announces four MERS cases from Saudi Arabia in recent weeks

A recent disease outbreak alert released by the World Health Organization (WHO) reported four laboratory-confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) from three regions in the Kingdom of Saudi Arabia.

21 Nov 2022

Additional mRNA COVID vaccine doses could salvage antibody responses in blood cancer patients

A third COVID-19 vaccine dose in this patients with blood cancers could enhance their antibody responses against SARS-CoV-2

21 Nov 2022

NIAID awards more than $12 million for the development of antiviral therapies

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, recently awarded more than $12 million to three institutions for the development of antiviral therapies to treat diseases caused by viruses with pandemic potential.

21 Nov 2022

Increase in Candida auris infections among EU/EEA nations between 2020 and 2021

Researchers evaluated the trends in Candida auris infections among European Union/European Economic Area (EU/EUA) nations between 2020 and 2021.

21 Nov 2022

Some parents may delay or avoid talking about vaccines with their child’s primary care provider

Parents may not always turn to health professionals for vaccine advice – and a small subset could even be avoiding the conversation – a new national poll suggests.

21 Nov 2022

Tackling Antimicrobial Resistance; A Conversation with the World Health Organisation

For World Antimicrobial Awareness Week (WAAW), we speak to Silvia Bertagnolio from the WHO, about the importance of raising awareness of antimicrobial resistance.

21 Nov 2022

Enormous rise in Acinetobacter bloodstream infection cases in initial two years of COVID-19

In a new study, researchers investigated Acinetobacter species bloodstream infection (BSI) case counts from a subset of laboratory data continuously reported during the initial two years of SARS-CoV-2 infections, i.e., from 2020 to 2021.

21 Nov 2022

Preparing for epidemics now and in the future

The World Health Organization (WHO) recently conducted a virtual press conference on global health emergencies on November 16, 2022. Margaret Harris hosted the conference at WHO Headquarters in Geneva. In addition, a broad panel of technical experts was present online and offline for discussion.

20 Nov 2022

Mistrust and polarization steer rural governments to reject federal public health funding

When Elko County commissioners rejected a $500,000 grant from the Centers for Disease Control and Prevention that could have helped the county create a health department or health district, Kayla Hopkins pleaded with them to reconsider.

20 Nov 2022

Path cleared for Georgia to launch work requirements for Medicaid

Georgia is set to become the only state to have work requirements for Medicaid coverage.

20 Nov 2022

As STDS proliferate, companies rush to market at-home test kits. But are they reliable?

Among the more remarkable legacies of the covid-19 pandemic is how quickly federal regulators, the health care industry, and consumers moved to make at-home testing a reliable tool for managing a public health crisis.

20 Nov 2022

Human case of swine-origin influenza A virus detected in Denmark, according to CDC study

Researchers detected a swine influenza A virus (IAV)-infected patient in routine surveillance at the National Influenza Center in Denmark. The detected influenza variant appeared distinct from any variant found previously in Denmark.

18 Nov 2022

World Antimicrobial Awareness Week: Preventing Antimicrobial Resistance Together

In this interview, News-Medical talks to Dr Javier Yugueros-Marcos, Head of the Antimicrobial Resistance and Veterinary Products Department at the World Organisation for Animal Health, about how the world can work together to promote the sustainable and responsible use of antimicrobials.

18 Nov 2022

How gut microbes influence immune response to SARS-CoV-2

An article published in Critical Reviews in Food Science and Nutrition journal provides an overview of the role of gut microbiota in shaping the host immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

17 Nov 2022

Pandemic News and Research

Further Reading

US experienced higher COVID-19 mortality during delta and omicron waves

Treating long covid is rife with guesswork

Schools, sheriffs, and syringes: State plans vary for spending $26B in opioid settlement funds

California aims to maximize health insurance subsidies for workers during labor disputes

Exploring antibiotic resistance in the EU

Elevated incidence and risk for a new diagnosis of diabetes after COVID-19

The WHO announces four MERS cases from Saudi Arabia in recent weeks

Additional mRNA COVID vaccine doses could salvage antibody responses in blood cancer patients

NIAID awards more than $12 million for the development of antiviral therapies

Increase in Candida auris infections among EU/EEA nations between 2020 and 2021

Some parents may delay or avoid talking about vaccines with their child’s primary care provider

Tackling Antimicrobial Resistance; A Conversation with the World Health Organisation

Enormous rise in Acinetobacter bloodstream infection cases in initial two years of COVID-19

Preparing for epidemics now and in the future

Mistrust and polarization steer rural governments to reject federal public health funding

Path cleared for Georgia to launch work requirements for Medicaid

As STDS proliferate, companies rush to market at-home test kits. But are they reliable?

Human case of swine-origin influenza A virus detected in Denmark, according to CDC study

World Antimicrobial Awareness Week: Preventing Antimicrobial Resistance Together

How gut microbes influence immune response to SARS-CoV-2

Best practices - optimize qPCR processes for pathogen detection eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News